{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:49:10Z","timestamp":1791085750152,"version":"4.1.0"},"reference-count":202,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/1469-0691.12556","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T03:03:05Z","timestamp":1390446185000},"page":"286-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":298,"title":["Leishmaniasis in immunosuppressed individuals"],"prefix":"10.1016","volume":"20","author":[{"given":"J.","family":"van Griensven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"L\u00f3pez-V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12556_bib1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12556_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/1469-0691.12556_bib3","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/1469-0691.12556_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/1469-0691.12556_bib6","doi-asserted-by":"crossref","first-page":"805108","DOI":"10.1155\/2013\/805108","article-title":"Mucosal leishmaniasis: an underestimated presentation of a neglected disease","volume":"2013","author":"Strazzulla","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1111\/1469-0691.12556_bib7","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1016\/j.ijid.2010.06.019","article-title":"Leishmaniasis, an emerging infection in travelers","volume":"14","author":"Pavli","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib8","doi-asserted-by":"crossref","first-page":"20544","DOI":"10.2807\/1560-7917.ES2013.18.30.20544","article-title":"Imported leishmaniasis in the Netherlands from 2005 to 2012: epidemiology, diagnostic techniques and sequence-based species typing from 195 patients","volume":"18","author":"Bart","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1111\/1469-0691.12556_bib9","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.26.20205-en","article-title":"Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010","volume":"17","author":"Gautret","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1111\/1469-0691.12556_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/cid\/cir468","article-title":"Patterns of illness in travelers visiting Mexico and Central America: the GeoSentinel experience","volume":"53","author":"Flores-Figueroa","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1708-8305.2009.00341.x","article-title":"Imported leishmaniasis: a heterogeneous group of diseases","volume":"16","author":"Perez-Ayala","year":"2009","journal-title":"J Travel Med"},{"key":"10.1111\/1469-0691.12556_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/00365540903104127","article-title":"Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis","volume":"41","author":"Buonomano","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib13","doi-asserted-by":"crossref","first-page":"20546","DOI":"10.2807\/1560-7917.ES2013.18.30.20546","article-title":"Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012","volume":"18","author":"Arce","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1111\/1469-0691.12556_bib14","doi-asserted-by":"crossref","first-page":"19505","DOI":"10.2807\/ese.15.10.19505-en","article-title":"Leishmaniasis emergence in Europe","volume":"15","author":"Ready","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1111\/1469-0691.12556_bib15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3201\/eid1407.071589","article-title":"Spread of vector-borne diseases and neglect of leishmaniasis, Europe","volume":"14","author":"Dujardin","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12556_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe","volume":"97","author":"Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1111\/1469-0691.12556_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12556_bib18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12556_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1198-743x.2001.00270.x","article-title":"Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART)","volume":"7","author":"Lopez-Velez","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12556_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1179\/000349803225002507","article-title":"Leishmania\/HIV co-infection in Brazil: an appraisal","volume":"97","author":"Rabello","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1111\/1469-0691.12556_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.trstmh.2012.01.008","article-title":"High frequency of asymptomatic Leishmania spp. infection among HIV-infected patients living in endemic areas for visceral leishmaniasis in Brazil","volume":"106","author":"Orsini","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.trstmh.2011.01.006","article-title":"The emergence of concurrent HIV-1\/AIDS and visceral leishmaniasis in Northeast Brazil","volume":"105","author":"Nascimento","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1590\/S0074-02762010000500016","article-title":"HIV\/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil","volume":"105","author":"Alexandrino-de-Oliveira","year":"2010","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1111\/1469-0691.12556_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0140-6736(96)90441-9","article-title":"HIV co-infection with a currently non-pathogenic flagellate","volume":"347","author":"Jimenez","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12556_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1590\/S0074-02761998000400021","article-title":"Parasite genotypically related to a monoxenous trypanosomatid of dog's flea causing opportunistic infection in an HIV positive patient","volume":"93","author":"Pacheco","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1111\/1469-0691.12556_bib26","doi-asserted-by":"crossref","first-page":"20535","DOI":"10.2807\/1560-7917.ES2013.18.29.20535","article-title":"The burden of visceral leishmaniasis in Italy from 1982 to 2012: a retrospective analysis of the multi-annual epidemic that occurred from 1989 to 2009","volume":"18","author":"Gramiccia","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1111\/1469-0691.12556_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/TP.0b013e31827c16e2","article-title":"The risk factors for and effects of visceral leishmaniasis in graft and renal transplant recipients","volume":"95","author":"Alves da Silva","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12556_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1399-3062.2010.00520.x","article-title":"Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management","volume":"12","author":"Veroux","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5301\/JN.2011.8343","article-title":"Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case","volume":"24","author":"Postorino","year":"2011","journal-title":"J Nephrol"},{"key":"10.1111\/1469-0691.12556_bib30","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/lt.21538","article-title":"Visceral leishmaniasis among liver transplant recipients: an overview","volume":"14","author":"Campos-Varela","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/1469-0691.12556_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(08)70043-4","article-title":"Leishmaniasis among organ transplant recipients","volume":"8","author":"Antinori","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1399-3062.2011.00598.x","article-title":"Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature","volume":"13","author":"Simon","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1365-2133.1998.02139.x","article-title":"Post-kala-azar dermal leishmaniasis with mucosal involvement in a kidney transplant recipient: treatment with liposomal amphotericin B","volume":"138","author":"Roustan","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1399-3046.2006.00660.x","article-title":"Liver transplant recipient with concomitant cutaneous and visceral leishmaniasis","volume":"11","author":"Ozcan","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1111\/1469-0691.12556_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1590\/S0074-02762002000500029","article-title":"Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient","volume":"97","author":"Gontijo","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1111\/1469-0691.12556_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.trre.2013.10.007","article-title":"Visceral leishmaniasis after kidney transplantation: report of a new case and a review of the literature","volume":"28","author":"Bouchekoua","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1111\/1469-0691.12556_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1704396","article-title":"Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients","volume":"33","author":"Sirvent-von Bueltzingsloewen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12556_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bmt.1705728","article-title":"Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Agteresch","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12556_bib39","first-page":"37","article-title":"Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients","volume":"116","author":"Rodriguez-Wilhelmi","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1111\/1469-0691.12556_bib40","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1111\/j.1432-2277.2012.01487.x","article-title":"Visceral leishmaniasis in hematopoietic stem cell transplantation","volume":"25","author":"Bautista","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/1469-0691.12556_bib41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-3156.2011.02816.x","article-title":"Endemic and opportunistic infections in Brazilian solid organ transplant recipients","volume":"16","author":"Batista","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1111\/1469-0691.12556_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S0036-46652009000600002","article-title":"Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center","volume":"51","author":"Machado","year":"2009","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1111\/1469-0691.12556_bib43","first-page":"186","article-title":"Leishmania in SLE mimicking an exacerbation","volume":"24","author":"Ossandon","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib44","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1590\/S0482-50042010000600009","article-title":"Felty's syndrome and Kala-azar: a challenge for the rheumatologist","volume":"50","author":"Viana","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"10.1111\/1469-0691.12556_bib45","first-page":"661","article-title":"Comment on \u2018Leishmania in SLE mimicking and exacerbation\u2019","volume":"25","author":"Castellino","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib46","first-page":"590","article-title":"Visceral leishmaniasis among immunosuppressed patients with rheumatic diseases","volume":"28","author":"Erre","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/RHU.0b013e3181c8aa33","article-title":"An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab","volume":"16","author":"Kritikos","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib48","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/rheumatology\/keh220","article-title":"Visceral leishmaniasis in a patient with Wegener's granulomatosis","volume":"43","author":"Sollima","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/1469-0691.12556_bib49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/RHU.0b013e3181dfd26f","article-title":"Visceral leishmaniasis mimicking systemic lupus erythematosus","volume":"16","author":"Arlet","year":"2010","journal-title":"J Clin Rheumatol"},{"issue":"suppl 2","key":"10.1111\/1469-0691.12556_bib50","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1136\/annrheumdis-2011-200596","article-title":"Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats","volume":"71","author":"Bogdan","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1469-0691.12556_bib51","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1469-0691.2011.03674.x","article-title":"Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe","volume":"18","author":"Zanger","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12556_bib52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semarthrit.2013.01.006","article-title":"Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases)","volume":"43","author":"Guedes-Barbosa","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/1469-0691.12556_bib53","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/rheumatology\/kes030","article-title":"Mucocutaneous leishmaniasis in a patient treated with anti-TNF-alpha therapy","volume":"51","author":"Garcia-Gonzalez","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/1469-0691.12556_bib54","first-page":"447","article-title":"Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab","volume":"52","author":"Gomes","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"10.1111\/1469-0691.12556_bib55","doi-asserted-by":"crossref","first-page":"20542","DOI":"10.2807\/1560-7917.ES2013.18.30.20542","article-title":"Leishmaniasis in the era of tumor necrosis factor alpha antagonist therapy\u2014a research agenda for Europe","volume":"18","author":"Zanger","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1111\/1469-0691.12556_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2334-6-177","article-title":"Leishmania infantum leishmaniasis in corticosteroid-treated patients","volume":"6","author":"Pittalis","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib57","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-0463.2006.apm_484.x","article-title":"Leishmania infection in a 51-year-old woman with sarcoidosis: case report","volume":"114","author":"Chianura","year":"2006","journal-title":"APMIS"},{"key":"10.1111\/1469-0691.12556_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1179\/136485905X19810","article-title":"Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate","volume":"99","author":"Garcia-Cordoba","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1111\/1469-0691.12556_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00108-007-1872-3","article-title":"Sepsis-like disease in an immunocompromised patient with a travel history to Mallorca","volume":"48","author":"Hagenah","year":"2007","journal-title":"Internist (Berl)"},{"key":"10.1111\/1469-0691.12556_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s15010-011-0109-5","article-title":"Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment","volume":"39","author":"Casabianca","year":"2011","journal-title":"Infection"},{"key":"10.1111\/1469-0691.12556_bib61","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.trstmh.2007.08.003","article-title":"Aspects of the association between leishmaniasis and malignant disorders","volume":"101","author":"Kopterides","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1111\/1469-0691.12556_bib63","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host\u2013pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/1469-0691.12556_bib64","doi-asserted-by":"crossref","first-page":"e1003053","DOI":"10.1371\/journal.ppat.1003053","article-title":"Determinants for the development of visceral leishmaniasis disease","volume":"9","author":"McCall","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1111\/1469-0691.12556_bib65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2011.05.012","article-title":"Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human","volume":"119","author":"Michel","year":"2011","journal-title":"Acta Trop"},{"key":"10.1111\/1469-0691.12556_bib66","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1016\/j.ijid.2012.12.024","article-title":"Visceral leishmaniasis: host\u2013parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host","volume":"17","author":"Saporito","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib67","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","article-title":"Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example","volume":"10","author":"Bogdan","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1111\/1469-0691.12556_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11908-009-0035-1","article-title":"Immunopathogenesis of AIDS","volume":"11","author":"Ortiz","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"10.1111\/1469-0691.12556_bib69","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/COH.0b013e32835211e9","article-title":"Mechanisms of interaction between protozoan parasites and HIV","volume":"7","author":"Andreani","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1111\/1469-0691.12556_bib70","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1471-2334-10-358","article-title":"High levels of T lymphocyte activation in Leishmania\u2013HIV-1 co-infected individuals despite low HIV viral load","volume":"10","author":"Santos-Oliveira","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib71","doi-asserted-by":"crossref","first-page":"e1198","DOI":"10.1371\/journal.pntd.0001198","article-title":"Evidence that lipopolysaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis","volume":"5","author":"Santos-Oliveira","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/1469-0691.12556_bib72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/infdis\/jit135","article-title":"Microbial translocation induces an intense proinflammatory response in patients with visceral leishmaniasis and HIV type 1 coinfection","volume":"208","author":"Santos-Oliveira","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib73","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1016\/j.jaci.2009.11.014","article-title":"Transplantation immunology: solid organ and bone marrow","volume":"125","author":"Chinen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/1469-0691.12556_bib74","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/CMR.00021-07","article-title":"Transmission of tropical and geographically restricted infections during solid-organ transplantation","volume":"21","author":"Martin-Davila","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12556_bib75","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.idc.2013.02.008","article-title":"Parasitic infections in solid organ transplant recipients","volume":"27","author":"Coster","year":"2013","journal-title":"Infect Dis Clin North Am"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12556_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/000349803225002589","article-title":"Leishmania and HIV co-infection: dermatological manifestations","volume":"97","author":"Puig","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1111\/1469-0691.12556_bib77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0190-9622(99)70342-7","article-title":"Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection","volume":"41","author":"Colebunders","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1469-0691.12556_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0151-9638(06)70841-9","article-title":"Leishmania infantum\/HIV co-infection: cutaneous lesions following treatment of visceral leishmaniasis","volume":"133","author":"Catorze","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/1469-0691.12556_bib79","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1046\/j.1365-2133.2000.03909.x","article-title":"Kaposi's sarcoma-like lesions and other nodules as cutaneous involvement in AIDS-related visceral leishmaniasis","volume":"143","author":"Gonzalez-Beato","year":"2000","journal-title":"Br J Dermatol"},{"issue":"suppl 2","key":"10.1111\/1469-0691.12556_bib80","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0929-693X(09)75316-3","article-title":"Pseudotumoral-like recurrence of visceral leishmaniasis in a seven-year-old girl","volume":"16","author":"Jeziorski","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1111\/1469-0691.12556_bib81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2133.1998.02326.x","article-title":"Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus","volume":"139","author":"Ara","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00000372-199504000-00006","article-title":"Atypical cutaneous histological features of visceral leishmaniasis in acquired immunodeficiency syndrome","volume":"17","author":"Perrin","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/1469-0691.12556_bib83","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archderm.142.6.787","article-title":"Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient","volume":"142","author":"Alsina-Gibert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/1469-0691.12556_bib84","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-4362.2002.01610.x","article-title":"Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis","volume":"41","author":"Bosch","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.actatropica.2003.09.009","article-title":"Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis","volume":"90","author":"Fernandez-Guerrero","year":"2004","journal-title":"Acta Trop"},{"key":"10.1111\/1469-0691.12556_bib86","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome","volume":"95","author":"Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib87","first-page":"451","article-title":"Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection","volume":"3","author":"Gilad","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"10.1111\/1469-0691.12556_bib88","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/ijd.12139","article-title":"Post-kala-azar dermal leishmaniasis in HIV-infected patients with AIDS: a report of two cases diagnosed in the USA","volume":"52","author":"Farooq","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/jinf.1999.0630","article-title":"Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum","volume":"40","author":"Ridolfo","year":"2000","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12556_bib90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1590\/S1413-86702002000600008","article-title":"Post-kala-azar dermal leishmaniasis associated with AIDS","volume":"6","author":"Bittencourt","year":"2002","journal-title":"Braz J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib91","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jinf.2005.09.015","article-title":"Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe","volume":"53","author":"Rihl","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12556_bib92","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1128\/JCM.44.3.1178-1180.2006","article-title":"Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient","volume":"44","author":"Stark","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12556_bib93","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clinbiochem.2007.10.008","article-title":"Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus","volume":"41","author":"Sakkas","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1111\/1469-0691.12556_bib94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2006.12.001","article-title":"Serum markers of rheumatoid arthritis in visceral leishmaniasis: rheumatoid factor and anti-cyclic citrullinated peptide antibody","volume":"28","author":"Atta","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1111\/1469-0691.12556_bib95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00296-004-0533-2","article-title":"Cryoglobulinemic purpura in visceral leishmaniasis","volume":"25","author":"Rizos","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1111\/1469-0691.12556_bib96","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/1529-0131(199909)42:9<2007::AID-ANR30>3.0.CO;2-X","article-title":"Mixed cryoglobulinemia secondary to visceral leishmaniasis","volume":"42","author":"Casato","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1469-0691.12556_bib97","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1136\/ard.2003.014480","article-title":"Visceral leishmaniasis resembling systemic lupus erythematosus","volume":"63","author":"Voulgari","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1469-0691.12556_bib98","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1016\/j.ijid.2008.09.012","article-title":"Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate","volume":"13","author":"Venizelos","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib99","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF02206670","article-title":"Visceral leishmaniasis mimicking a flare of systemic lupus erythematosus","volume":"10","author":"Braun","year":"1991","journal-title":"Clin Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3347\/kjp.2012.50.2.133","article-title":"Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap","volume":"50","author":"Tunccan","year":"2012","journal-title":"Korean J Parasitol"},{"key":"10.1111\/1469-0691.12556_bib101","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/rheumatology\/kel235","article-title":"Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab","volume":"45","author":"Bassetti","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/1469-0691.12556_bib102","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","article-title":"TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists","volume":"50","author":"Williams","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib103","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2169\/internalmedicine.35.502","article-title":"Visceral leishmaniasis misdiagnosed as malignant lymphoma","volume":"35","author":"Kawakami","year":"1996","journal-title":"Intern Med"},{"key":"10.1111\/1469-0691.12556_bib104","doi-asserted-by":"crossref","first-page":"308","DOI":"10.12968\/hosp.2003.64.5.1767","article-title":"Visceral leishmaniasis misdiagnosed as probable acute lymphoblastic leukaemia","volume":"64","author":"Jones","year":"2003","journal-title":"Hosp Med"},{"key":"10.1111\/1469-0691.12556_bib105","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1542\/peds.106.4.e58","article-title":"Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children\u2014a series of 12 cases","volume":"106","author":"Gagnaire","year":"2000","journal-title":"Pediatrics"},{"key":"10.1111\/1469-0691.12556_bib106","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2008.02.013","article-title":"Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis\u2014case report and systematic review","volume":"56","author":"Rajagopala","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12556_bib107","first-page":"50","article-title":"Monoclonal gammopathy in human leishmaniasis","volume":"64","author":"Randi","year":"2006","journal-title":"Neth J Med"},{"key":"10.1111\/1469-0691.12556_bib108","first-page":"52","article-title":"A case of visceral leishmaniasis misdiagnosed as autoimmune hepatitis","volume":"16","author":"Dalgic","year":"2005","journal-title":"Turk J Gastroenterol"},{"key":"10.1111\/1469-0691.12556_bib109","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.ijid.2008.08.011","article-title":"Polyclonal hypergammaglobulinemia and high smooth-muscle autoantibody titers with specificity against filamentous actin: consider visceral leishmaniasis, not just autoimmune hepatitis","volume":"13","author":"Makaritsis","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib110","first-page":"503","article-title":"Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature","volume":"27","author":"De Leonardis","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib111","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1007\/s00296-012-2483-4","article-title":"Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis","volume":"33","author":"Besada","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1111\/1469-0691.12556_bib112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.actatropica.2013.06.009","article-title":"Utility of the microculture method for Leishmania detection in non-invasive samples obtained from a blood bank","volume":"128","author":"Ates","year":"2013","journal-title":"Acta Trop"},{"key":"10.1111\/1469-0691.12556_bib113","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/jcm.33.4.937-939.1995","article-title":"Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"33","author":"Lopez-Velez","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12556_bib114","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/jcm.30.12.3284-3285.1992","article-title":"Peripheral intramonocytic leishmanias in an AIDS patient","volume":"30","author":"Fillola","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12556_bib115","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.02297-05","article-title":"Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis","volume":"44","author":"Cruz","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12556_bib116","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.1998.59.155","article-title":"The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1","volume":"59","author":"Medrano","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib117","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4269\/ajtmh.1992.47.764","article-title":"Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes","volume":"47","author":"Mary","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib118","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1371\/journal.pntd.0001665","article-title":"The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis","volume":"6","author":"Cota","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/1469-0691.12556_bib119","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4269\/ajtmh.12-0527","article-title":"Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-infected patients","volume":"89","author":"Molina","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib120","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.41.11.5080-5084.2003","article-title":"Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis","volume":"41","author":"Bossolasco","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12556_bib121","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/518167","volume":"44","author":"Antinori","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.1111\/1469-0691.12556_bib122","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0035-9203(02)90074-X","article-title":"A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus","volume":"96","author":"Cruz","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib123","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.trstmh.2007.09.003","article-title":"Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent","volume":"102","author":"Boelaert","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib124","first-page":"899","article-title":"Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV\u2013Leishmania coinfection: value in diagnosis and post-treatment follow-up","volume":"23","author":"Riera","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.2012.11-0682","article-title":"Leishmaniasis in the United States: treatment in 2012","volume":"86","author":"Murray","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/515085","article-title":"Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib127","series-title":"Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010. WHO technical report series 949 (2010)","article-title":"Control of the leishmaniasis","author":"World Health Organization","year":"2010"},{"key":"10.1111\/1469-0691.12556_bib128","unstructured":"Panel on Opportunistic Infections in HIV-infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents:recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America (2013)."},{"key":"10.1111\/1469-0691.12556_bib129","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/cid\/cir521","article-title":"Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India","volume":"53","author":"Sinha","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection","volume":"43","author":"Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib131","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/425359","article-title":"Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection","volume":"39","author":"Sindermann","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib132","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/00365540701787800","article-title":"Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients","volume":"40","author":"Marques","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib133","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00365540701466215","article-title":"Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients","volume":"40","author":"Troya","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib134","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(12)70348-1","article-title":"HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals","volume":"13","author":"van Griensven","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib136","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-3024.2006.00900.x","article-title":"Immune reconstitution disease associated with parasitic infections following antiretroviral treatment","volume":"28","author":"Lawn","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1111\/1469-0691.12556_bib137","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"ter Horst","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib138","doi-asserted-by":"crossref","first-page":"e1153","DOI":"10.1371\/journal.pntd.0001153","article-title":"Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review","volume":"5","author":"Cota","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/1469-0691.12556_bib139","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4269\/ajtmh.2010.09-0594","article-title":"Visceral leishmaniasis treated with antimonials\/paromomycin followed by itraconazole\/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient","volume":"83","author":"Barragan","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib140","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jac\/dkh084","article-title":"Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients","volume":"53","author":"Lopez-Velez","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 4","key":"10.1111\/1469-0691.12556_bib141","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/ajt.12120","article-title":"Parasitic infections in solid organ transplantation","volume":"13","author":"Schwartz","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12556_bib142","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00007890-200009150-00016","article-title":"Therapy of visceral leishmaniasis in renal transplant recipients intolerant to pentavalent antimonials","volume":"70","author":"Llorente","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12556_bib143","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/37.5.1042","article-title":"Fluconazole plus allopurinol in treatment of visceral leishmaniasis","volume":"37","author":"Torrus","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12556_bib144","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/clind\/16.3.397","article-title":"Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate","volume":"16","author":"Halim","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib145","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1093\/ndt\/14.12.2941","article-title":"The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate\u2014cure with ketoconazole and allopurinol","volume":"14","author":"Hueso","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/1469-0691.12556_bib146","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eimc.2009.03.017","article-title":"Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review","volume":"28","author":"Moreno","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/1469-0691.12556_bib147","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/j.1600-6143.2008.02397.x","article-title":"Donor infection and transmission to the recipient of a solid allograft","volume":"8","author":"Len","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12556_bib148","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3201\/eid1510.090881","article-title":"Appropriate screening for leishmaniasis before immunosuppressive treatments","volume":"15","author":"Cascio","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib149","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3201\/eid1506.090101","article-title":"Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe","volume":"15","author":"Xynos","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10096-008-0628-x","article-title":"Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention","volume":"28","author":"Garcia-Vidal","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib151","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1399-3062.2010.00517.x","article-title":"Expanded infectious diseases screening program for Hispanic transplant candidates","volume":"12","author":"Fitzpatrick","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib152","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4269\/ajtmh.2012.11-0479","article-title":"Assessment of interferon-gamma levels and leishmanin skin test results in persons recovered for leishmaniasis","volume":"87","author":"Alimohammadian","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib153","doi-asserted-by":"crossref","first-page":"e1042","DOI":"10.1371\/journal.pntd.0001042","article-title":"Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study","volume":"5","author":"Gidwani","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/1469-0691.12556_bib154","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4269\/ajtmh.2010.09-0605","article-title":"Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection","volume":"83","author":"Turgay","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib155","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.5588\/ijtld.12.0111","article-title":"Screening for latent tuberculosis in anti-TNF-alpha candidate patients in a high tuberculosis incidence setting","volume":"16","author":"Saidenberg-Kermanac'h","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/1469-0691.12556_bib156","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/cid\/cit488","article-title":"Challenging issues in tuberculosis in solid organ transplantation","volume":"57","author":"Horne","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib157","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.bmt.1705006","article-title":"Chagas disease in bone marrow transplantation: an approach to preemptive therapy","volume":"36","author":"Altclas","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12556_bib158","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ajt.12521","article-title":"High prevalence of asymptomatic Leishmania spp. infection among liver transplant recipients and donors from an endemic area of Brazil","volume":"14","author":"Clemente","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12556_bib159","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0035-9203(03)90109-X","article-title":"Leishmania major and HIV co-infection in Burkina Faso","volume":"97","author":"Guiguemde","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-4632.2012.05615.x","article-title":"Dissemination of localized cutaneous leishmaniasis in an organ transplant recipient: case report and literature review","volume":"52","author":"Zandieh","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib161","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1093\/ndt\/gfm520","article-title":"A typical presentation of cutaneous leishmaniasis after renal transplantation","volume":"22","author":"Vinhal","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/1469-0691.12556_bib162","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5144\/0256-4947.2012.01.7.1510","article-title":"Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole","volume":"33","author":"Yaich","year":"2013","journal-title":"Ann Saudi Med"},{"key":"10.1111\/1469-0691.12556_bib163","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tmaid.2013.05.003","article-title":"Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-alpha antagonists","volume":"11","author":"Neumayr","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib164","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D30C96W76K","article-title":"Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab","volume":"18","author":"Romero-Mate","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1111\/1469-0691.12556_bib165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000258675","article-title":"Localized cutaneous leishmaniasis due to Leishmania infantum in a patient treated with infliximab","volume":"220","author":"Hakimi","year":"2010","journal-title":"Dermatology"},{"key":"10.1111\/1469-0691.12556_bib166","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/00365548.2012.752859","article-title":"Cutaneous leishmaniasis in a patient receiving infliximab","volume":"45","author":"Hernandez-Torres","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib167","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-4632.2006.03096.x","article-title":"Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids\u2014first report","volume":"46","author":"Tuon","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib168","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2133.2009.09201.x","article-title":"Presentation of leishmaniasis (Leishmania infantum) in the skin of a patient with severe atopic dermatitis","volume":"161","author":"Kerr","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib169","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4269\/ajtmh.2011.11-0075","article-title":"American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian Amazon","volume":"85","author":"Guerra","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2133.2008.08908.x","article-title":"Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World","volume":"160","author":"Lindoso","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/1469-0691.12556_bib171","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0151-9638(06)70958-9","article-title":"Cutaneous leishmania in HIV patient in Ouagadougou: clinical and therapeutic aspects","volume":"133","author":"Niamba","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/1469-0691.12556_bib172","first-page":"282","article-title":"Diffuse cutaneous leishmaniasis and acquired immunodeficiency syndrome in a Senegalese patient","volume":"89","author":"Ndiaye","year":"1996","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1111\/1469-0691.12556_bib173","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.03.012","article-title":"Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases","volume":"63","author":"Faucher","year":"2011","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12556_bib174","doi-asserted-by":"crossref","first-page":"340","DOI":"10.26719\/2010.16.3.340","article-title":"Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran","volume":"16","author":"Jafari","year":"2010","journal-title":"East Mediterr Health J"},{"key":"10.1111\/1469-0691.12556_bib175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4269\/ajtmh.2008.79.435","article-title":"Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran","volume":"79","author":"Alborzi","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib176","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/497338","article-title":"Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS","volume":"192","author":"Posada-Vergara","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib177","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1708-8305.2008.00286.x","article-title":"Treatment of cutaneous leishmaniasis in travelers 2009","volume":"16","author":"Blum","year":"2009","journal-title":"J Travel Med"},{"key":"10.1111\/1469-0691.12556_bib178","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/S0365-05962011000300012","article-title":"Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review","volume":"86","author":"Almeida","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1111\/1469-0691.12556_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005067.pub3","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"Gonzalez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/1469-0691.12556_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004834.pub2","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","author":"Gonzalez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/1469-0691.12556_bib181","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s40265-013-0132-1","article-title":"Therapeutic options for Old World cutaneous leishmaniasis and New World cutaneous and mucocutaneous leishmaniasis","volume":"73","author":"Monge-Maillo","year":"2013","journal-title":"Drugs"},{"key":"10.1111\/1469-0691.12556_bib182","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.md.0000076009.64510.b8","article-title":"Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients","volume":"82","author":"Aliaga","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/1469-0691.12556_bib183","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/bmt.2012.190","article-title":"Duodenal leishmaniasis after allogeneic hematopoietic SCT","volume":"48","author":"Martinez-Losada","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12556_bib184","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.gastrohep.2012.12.001","article-title":"Diarrhea due to visceral leishmaniasis in a liver transplant recipient","volume":"36","author":"Vargas Acosta","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"10.1111\/1469-0691.12556_bib185","first-page":"A5958","article-title":"Visceral leishmaniasis: not only a tropical disease","volume":"157","author":"Cuperus","year":"2013","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1111\/1469-0691.12556_bib186","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5694\/mja12.11003","article-title":"Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis","volume":"198","author":"Berry","year":"2013","journal-title":"Med J Aust"},{"key":"10.1111\/1469-0691.12556_bib187","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.11.2011.5199","article-title":"Visceral leishmaniasis in immunosuppressed Caucasian patient","volume":"2012","author":"Toqeer","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1111\/1469-0691.12556_bib188","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/RHU.0b013e31823f0089","article-title":"Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate","volume":"18","author":"Karagiannidis","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib189","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/RHU.0b013e318289e7e3","article-title":"Comment on; visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate'","volume":"19","author":"Guirao-Arrabal","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/1469-0691.12556_bib190","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jfo.2012.06.007","article-title":"Infectious complications in patients treated with anti-TNF-alpha: two cases of leishmaniasis","volume":"35","author":"Bousquet","year":"2012","journal-title":"J Fr Ophtalmol"},{"key":"10.1111\/1469-0691.12556_bib191","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2010.2878","article-title":"Let off the leash: kala-azar following the use of tumour necrosis factor antibodies","volume":"2010","author":"Khan","year":"2010","journal-title":"BMJ Case Rep"},{"key":"10.1111\/1469-0691.12556_bib192","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/00006454-199610000-00020","article-title":"Visceral leishmaniasis in three children with leukemia","volume":"15","author":"Di Cataldo","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12556_bib193","first-page":"729","article-title":"Association of acute lymphoblastic leukaemia and visceral leishmaniasis","volume":"69","author":"Nafil","year":"2011","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1111\/1469-0691.12556_bib194","first-page":"878","article-title":"Testicular leishmaniasis in a boy with acute lymphoblastic leukemia","volume":"38","author":"Kapila","year":"1994","journal-title":"Acta Cytol"},{"key":"10.1111\/1469-0691.12556_bib195","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/0002-9343(87)90948-X","article-title":"Visceral leishmaniasis in immunocompromised hosts","volume":"83","author":"Fernandez-Guerrero","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/1469-0691.12556_bib196","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/1469-0691.12556_bib197","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/0037-8682-0033-2012","article-title":"Human immunodeficiency virus\/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010","volume":"46","author":"Lima","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1111\/1469-0691.12556_bib198","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4269\/ajtmh.13-0239","article-title":"Comparison of parasitological, serological, and molecular tests for visceral leishmaniasis in HIV-infected patients: a cross-sectional delayed-type study","volume":"89","author":"Cota","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/1469-0691.12556_bib199","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/JCM.38.1.236-240.2000","article-title":"Optimized PCR using patient blood samples for diagnosis and follow-up of visceral leishmaniasis, with special reference to AIDS patients","volume":"38","author":"Lachaud","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12556_bib200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s100960050503","article-title":"Detection of Leishmania in immunocompromised patients using peripheral blood spots on filter paper and the polymerase chain reaction","volume":"19","author":"Campino","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12556_bib201","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-3156.2004.01251.x","article-title":"Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal","volume":"9","author":"Rijal","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1111\/1469-0691.12556_bib202","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.38917.503056.7C","article-title":"A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis","volume":"333","author":"Chappuis","year":"2006","journal-title":"BMJ"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14602743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14602743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:12:46Z","timestamp":1761117166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14602743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":202,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1198743X14602743"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12556","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmaniasis in immunosuppressed individuals","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1469-0691.12556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}